Elanco Animal Health vs Smith & Nephew

Elanco Animal Health (ELAN), health care, and Smith & Nephew (SNN), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Elanco Animal Health and Smith & Nephew are valued at about the same: $12.9B and $12.8B. Over the past year Elanco Animal Health's share price has moved +23.5% and Smith & Nephew's -4.82%.

Key facts

Elanco Animal Health market value
$12.9B
Smith & Nephew market value
$12.8B
Smith & Nephew P/E
21.0
Elanco Animal Health revenue
$4.7BFY to 2025-12-31
Smith & Nephew revenue
$6.2BFY to 2025-12-31
Superinvestors holding both
1

Market values as of .

Elanco Animal Health vs Smith & Nephew: every measure side by side
Measure Elanco Animal Health Smith & Nephew
SectorHealth CareHealth Care
Country United States United Kingdom
Fiscal year ends2025-12-312025-12-31
Size
Market cap$12.9Bhigher$12.8Blower
Revenue$4.7Blower$6.2Bhigher
Earnings-$232Mlower$625Mhigher
Employees9,400lower17,000higher
Total assets$13.4Bhigher$10.5Blower
Valuation
P/E—21.0
P/S2.7higher2.1lower
P/B1.9—
Dividend yield0.00%—
Profitability
Operating margin—12.9%
Balance sheet
Net assets$6.5Bhigher$5.3Blower
Total liabilities$6.8Bhigher$5.2Blower
Total debt$4Bhigher$3.1Blower
Cash on hand$545Mlower$557Mhigher
Price change
Today-2.12%lower-1.49%higher
1 year+23.5%higher-4.82%lower

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (1)

Elanco Animal Health only (4)

Smith & Nephew only (1)

Percentages are each holding's share of that investor's reported portfolio (under "Both": Elanco Animal Health / Smith & Nephew). Who owns ELAN · Who owns SNN

Further comparisons

Learn

Questions and answers

Which is bigger, Elanco Animal Health or Smith & Nephew?

By market value, Elanco Animal Health is the larger: $12.9B against $12.8B for Smith & Nephew. By revenue in its latest fiscal year, Smith & Nephew is the larger: $6.2B against $4.7B for Elanco Animal Health.

Which has more debt?

Elanco Animal Health: $4B, against $3.1B for Smith & Nephew. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

Which superinvestors own both Elanco Animal Health and Smith & Nephew?

In their latest 13F filings, Charles Brandes (founder) holds both.

Cite this page

Funkfolio, “Elanco Animal Health vs Smith & Nephew”, data as of 18 November 2026. https://funkfolio.com/compare/elan-vs-snn

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.